dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Ruiz de Morales, José María G. |
dc.contributor.author | Puig, Lluís |
dc.contributor.author | Daudén, Esteban |
dc.contributor.author | Cañete, Juan D. |
dc.contributor.author | Pablos, José Luis |
dc.contributor.author | Olveira Martín, Antonio |
dc.contributor.author | Montalban Gairín, Xavier |
dc.contributor.author | Borruel Sainz, Natalia |
dc.contributor.author | Orti Pascual, Guillem |
dc.date.accessioned | 2021-10-01T08:06:18Z |
dc.date.available | 2021-10-01T08:06:18Z |
dc.date.issued | 2020-01 |
dc.identifier.citation | Ruiz de Morales JMG, Puig L, Daudén E, Cañete JD, Pablos JL, Martín AO, et al. Critical role of interleukin (IL)-17 in inflammatory and immune disorders: An updated review of the evidence focusing in controversies. Autoimmun Rev. 2020 Jan;19:102429. |
dc.identifier.issn | 1568-9972 |
dc.identifier.uri | https://hdl.handle.net/11351/6373 |
dc.description | Medicaments biològics; Inflamació; Psoriasi |
dc.description.sponsorship | This work was supported by Novartis Pharmaceuticals Spain. |
dc.language.iso | eng |
dc.publisher | Elsevier |
dc.relation.ispartofseries | Autoimmunity Reviews;19 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Psoriasi |
dc.subject | Citocines - Immunologia |
dc.subject.mesh | Psoriasis |
dc.subject.mesh | Cytokines |
dc.subject.mesh | /immunology |
dc.title | Critical role of interleukin (IL)-17 in inflammatory and immune disorders: An updated review of the evidence focusing in controversies |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1016/j.autrev.2019.102429 |
dc.subject.decs | psoriasis |
dc.subject.decs | citocinas |
dc.subject.decs | /inmunología |
dc.relation.publishversion | https://doi.org/10.1016/j.autrev.2019.102429 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Ruiz de Morales JMG] Inmunology Unit, Complejo Asistencial Universitario e Instituto de Biomedicina Universidad de León (IBIOMED), León, Spain. [Puig L] Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. Facultat de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. [Daudén E] Dermatology Department, Instituto de Investigación Sanitaria La Princesa (IIS-IP), Hospital Universitario de la Princesa, Madrid, Spain. [Cañete JD] Arthritis Unit, Rheumatology Dpt.,Hospital Clinic and IDIBAPS, Barcelona, Spain. [Pablos JL] Rheumatology Department, Hospital 12 de Octubre, Instituto de Investigación Hospital 12 de Octubre, Madrid, Spain. [Martín AO] Gastroenterology Department, La Paz Universitary Hospital, Madrid, Spain. [Montalbán X] Servei de Neurologia/Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain. Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vall d'Hebron Hospital Universitari, Barcelona, Spain. [Borruel N] Unitat d’Atenció Crohn-Colitis, Unitat de Recerca en Aparell Digestiu, Vall d'Hebron Hospital Universitari, Barcelona, Spain. [Ortí G] Servei d’Hematologia, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain |
dc.identifier.pmid | 31734402 |
dc.identifier.wos | 000508749200008 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |